John H. Rex

Director Técnico/Científico/I+D en F2G Ltd. .

Health Technology

Consumer Services

Technology Services

Perfil

John H.
Rex is currently the Chief Medical Officer & Director at F2G Ltd.
He is also an Operating Partner at Advent Venture Partners LLP.
Previously, he served as the Vice Chairman at CLSI, Inc. and as the Head-Infection & Global Medicines Development at AstraZeneca GmbH from 2003 to 2016.
Dr. Rex completed his undergraduate degree at Rice University and obtained a doctorate from Baylor College of Medicine.

Cargos activos de John H. Rex

Empresas	Cargo	Inicio
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.	Director Técnico/Científico/I+D	02/11/2016
Advent Venture Partners LLP Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.	Consultor / Asesor	01/11/2015

Todos los cargos activos de John H. Rex

Antiguos cargos conocidos de John H. Rex.

Empresas	Cargo	Fin
AstraZeneca GmbH AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma.	Corporate Officer/Principal	01/10/2016
CLSI, Inc. CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de John H. Rex.

Formación de John H. Rex.

Rice University	Undergraduate Degree
Baylor College of Medicine	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de John H. Rex.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.	Health Technology
AstraZeneca GmbH AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma.	Health Technology
CLSI, Inc. CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992.	Technology Services
Advent Venture Partners LLP Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.	Finance

Ver las conexiones de la empresa